Logo image
Non-thermal Plasma Induces Apoptosis in Melanoma Cells via Production of Intracellular Reactive Oxygen Species
Journal article   Open access   Peer reviewed

Non-thermal Plasma Induces Apoptosis in Melanoma Cells via Production of Intracellular Reactive Oxygen Species

Rachel Sensenig, Sameer Kalghatgi, Ekaterina Cerchar, Gregory Fridman, Alexey Shereshevsky, Behzad Torabi, Krishna Priya Arjunan, Erica Podolsky, Alexander Fridman, Gary Friedman, …
Annals of biomedical engineering, v 39(2), pp 674-687
Feb 2011
PMID: 21046465
url
https://doi.org/10.1007/s10439-010-0197-xView
Published, Version of Record (VoR) Open

Abstract

Non-thermal plasma Reactive oxygen species Cancer therapy Apoptosis Plasma medicine
Non-thermal atmospheric pressure dielectric barrier discharge (DBD) plasma may provide a novel approach to treat malignancies via induction of apoptosis. The purpose of this study was to evaluate the potential of DBD plasma to induce apoptosis in melanoma cells. Melanoma cells were exposed to plasma at doses that did not induce necrosis, and cell viability and apoptotic activity were evaluated by Trypan blue exclusion test, Annexin-V/PI staining, caspase-3 cleavage, and TUNEL ® analysis. Trypan blue staining revealed that non-thermal plasma treatment significantly decreased the viability of cells in a dose-dependent manner 3 and 24 h after plasma treatment. Annexin-V/PI staining revealed a significant increase in apoptosis in plasma-treated cells at 24, 48, and 72 h post-treatment ( p< 0.001). Caspase-3 cleavage was observed 48 h post-plasma treatment at a dose of 15 J/cm 2 . TUNEL ® analysis of plasma-treated cells demonstrated an increase in apoptosis at 48 and 72 h post-treatment ( p< 0.001) at a dose of 15 J/cm 2 . Pre-treatment with N -acetyl-L-cysteine (NAC), an intracellular reactive oxygen species (ROS) scavenger, significantly decreased apoptosis in plasma-treated cells at 5 and 15 J/cm 2 . Plasma treatment induces apoptosis in melanoma cells through a pathway that appears to be dependent on production of intracellular ROS. DBD plasma production of intracellular ROS leads to dose-dependent DNA damage in melanoma cells, detected by γ -H2AX, which was completely abrogated by pre-treating cells with ROS scavenger, NAC. Plasma-induced DNA damage in turn may lead to the observed plasma-induced apoptosis. Since plasma is non-thermal, it may be used to selectively treat malignancies.

Metrics

6 Record Views
152 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Engineering, Biomedical
Logo image